AKT1 and leukemia: Mechanistically, PSMs have been shown to promote differentiation (PSMD4) [44] and proliferation (PSMB8) [36] of leukemia cell lines through the nuclear factor kappa–B (NF–κB) and the phosphatidylinositol 3–kinase (PI3K)/protein kinase B (AKT) pathways.